Sarcouncil Journal of Internal Medicine and Public Health

Abstract: Regulatory labeling is now recognized as a sensitive aspect of product compliance and patient safety in a highly globalized marketplace in the pharmaceutical, medical device, and consumer goods industries. Nevertheless, the multinational companies experience deep difficulties in their attainment of consistent regulatory compliance, as the requirements of different health authorities in terms of labeling are diverse and even contradictory in various regions. The paper discusses the fact that global labeling is a multi-dimensional issue that impacts the complexity of dealing with divergent regulatory systems, finding a way to harmonize label content using Company Core Data Sheets (CCDS), the process of managing multilingual translations, post-marketing updates, and the adoption of new digital labeling systems. It brings to light operational, legal, and strategic consequences of these challenges and offers a series of systematic recommendations regarding how to have an effective global labeling governance model. Through comparison of traditional and digital labeling strategies, the paper highlights the significance of regulatory intelligence, technological integration, and cross-functional collaboration in ensuring compliance across the world. With the ever-changing regulatory expectations, organizations should be adaptive and patient-centered in labeling to reduce the risk, increase transparency, and facilitate access to the products internationally.